Merck Resumes Xirallic Production in Japan

Merck KGaA resumed normal operations at the Onahama production site in Japan on May 8. Among other products, the Onahama site manufactures Xirallic effect pigments, which are widely used in high-quality automotive coatings by companies such as Chrysler Group, Toyota Motor, General Motors and Ford Motor.

The damage to the production units and infrastructure caused by the catastrophic earth­quake in northeastern Japan on March 11 resulted in the stoppage of pigment production in Onahama. The recovery and repair work, which began on April 4, has been completed ahead of schedule. Merck said it expects the plant will achieve its regular production output in June.

The Onahama site (southern part of Iwaki City) is located 57 km south of the damaged Fukushima Daiichi nuclear power plant, and outside the evacuation zone. Merck is continually monitoring all public directives regarding radiation levels in order to ensure the safety of its employees. The company is also testing the products being shipped from Merck Japan to ensure that they comply fully with all regulations and safety standards.

Apart from Onahama, Merck will establish an alternative production site for Xirallic effect pigments. It is planned to have additional capacity for Xirallic pigments in Germany by the end of 2011. This will considerably boost future supply reliability of Xirallic products as of 2012.

Company

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.